Sun Hui-Chuan, Tang Zhao-You, Ma Zeng-Chen, Qin Lun-Xiu, Wang Lu, Ye Qin-Hai, Fan Jia, Wu Zhi-Quan, Zhou Xin-Da
Liver Cancer Institute and Zhong Shan Hospital, Fudan University, 200032 Shanghai, PR China.
J Cancer Res Clin Oncol. 2005 May;131(5):284-8. doi: 10.1007/s00432-004-0645-9. Epub 2005 Jan 21.
Second resection has been proved to be a safe and effective treatment for patients with intrahepatic recurrent HCC after primary resection; however, preoperative prognostic factors for outcome following second resection in patients with a hepatitis B virus (HBV) infection background remains to be clarified.
Fifty-seven patients with intrahepatic recurrent an HCC and HBV infection background received second resection from 1997 to 2003 in our institute. All of them were negative for anti-hepatitis C virus (HCV) and positive regarding HBV profile. Patient and tumor factors were analyzed.
At the time of preparing this paper, 31 had re-recurrence and 21 patients had died. No postoperative mortality was noted. The 1-, 3-, and 5-year overall survival after second resection were 69.9%, 61.2%, and 30.6%, respectively. Univariate and multivariate analysis showed that vascular invasion and time to recurrence were the independent prognostic factors for overall survival following second resection. The 3- and 4-year overall survival after second resection were 57.7% and 46.6% in patients with the presence of any of two risk factors (n = 46), and 100% and 100% in those with absence of both risk factors (n = 11, P = 0.008).
Vascular invasion and time to recurrence were the prognostic factors for overall survival following second resection of intrahepatic recurrent HCC.